DIFFUSE INTRINSIC PONTINE GLIOMA
Clinical trials for DIFFUSE INTRINSIC PONTINE GLIOMA explained in plain language.
Never miss a new study
Get alerted when new DIFFUSE INTRINSIC PONTINE GLIOMA trials appear
Sign up with your email to follow new studies for DIFFUSE INTRINSIC PONTINE GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental brain cancer treatment trial for children and adults
Disease control TerminatedThis study tested an experimental treatment called Antineoplaston therapy for DIPG, a rare and aggressive brain cancer that's difficult to treat. The trial aimed to see if this treatment could shrink tumors and help patients live longer. It was designed for children and adults wi…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE2 • Sponsor: Burzynski Research Institute • Aim: Disease control
Last updated Apr 04, 2026 03:35 UTC
-
New hope for kids with deadly brain tumors: experimental therapy targets cancer directly in the brain
Disease control OngoingThis early-stage study is testing a new type of personalized cell therapy called SC-CAR4BRAIN for children and young adults with aggressive brain tumors that have come back or not responded to standard treatments. Doctors collect the patient's own immune cells, modify them in a l…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1 • Sponsor: Seattle Children's Hospital • Aim: Disease control
Last updated Apr 04, 2026 03:34 UTC
-
Electric cap tested to fight Kids' brain cancer
Disease control OngoingThis trial is testing a wearable medical device called Optune for children with aggressive brain tumors. For one group, it tests if children can tolerate wearing the device for many hours a day to treat recurrent tumors. For another group with a newly diagnosed, hard-to-treat bra…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: NA • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
New hope for kids with deadly brain tumors: trial tests Immune-Boosting drug
Disease control OngoingThis study is testing whether adding an immunotherapy drug called indoximod to standard chemotherapy and radiation can better control aggressive brain tumors in children and young adults. It is for patients aged 3 to 21 with specific types of progressive brain cancer or newly dia…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE2 • Sponsor: Theodore S. Johnson • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New hope for kids with devastating brain cancer: first safety trial of experimental drug
Disease control OngoingThis study is testing the safety of a new oral drug called PTC596 (Unesbulin) when given alongside standard radiation therapy to children and young adults newly diagnosed with aggressive brain tumors, including a very hard-to-treat type called DIPG. The main goals are to find the…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1 • Sponsor: Nationwide Children's Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
New vaccine trial aims to train Kids' immune systems to fight deadly brain cancers
Disease control OngoingThis study is testing a cancer vaccine called SurVaxM in children and young adults with aggressive brain tumors that have come back or progressed. The vaccine is designed to teach the body's immune system to find and destroy cancer cells that carry a specific protein called survi…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1 • Sponsor: Children's Oncology Group • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for kids with tough cancers: trial tests personalized immune cell treatment
Disease control OngoingThis early-stage study is testing a new, personalized treatment for children with two aggressive cancers: recurrent neuroblastoma or a newly diagnosed brain stem tumor called DIPG. Doctors create a custom treatment using the patient's own immune cells and tumor material, aiming t…
Matched conditions: DIFFUSE INTRINSIC PONTINE GLIOMA
Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control
Last updated Mar 17, 2026 12:55 UTC